CrossrefInfokarte
Vitiligo Following Dupilumab Therapy for Moderate-to-Severe Atopic Dermatitis: A Case Report with Insight into Type 1/Type 2 Immune Imbalance
Clinical, Cosmetic and Investigational Dermatology · 2026-11 · Volume 19 · 1-5
DOI: 10.2147/ccid.s643447 ↗Abstract
Kein Abstract verfügbar.
EUVIMED